UNSPSC 51292600: Antidepressant benzodiazepines

Antidepressant drugs made from a group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring, hence the term BENZO-DIAZEPINE, BENZO-DIAZEPINES, and BENZODIAZEPINES.

UNSPSC 51292600 Antidepressant benzodiazepines is a Class code that does not align with the recent state and local solicitation activity appearing under it. The three most recent opportunities tagged to this code are procuring naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products—none of which represent antidepressant benzodiazepine medications or their distribution. The mismatch suggests either miscoding within the source data or a broad catch-all application of this UNSPSC designation to pharmaceutical procurement more generally rather than the specific drug class the code names.

The issuing bodies span state health agencies and cooperative purchasing alliances: Seminole County, Florida procured naloxone and drug deactivation systems through an IFB with a July 26, 2023 deadline; the Texas Health and Human Services Commission issued an RFI in April 2026 to explore direct-to-manufacturer prescription contracting; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, released an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products, with responses due March 26, 2026, and contract awards effective July 1, 2026. Without recent opportunities clearly aligned to the nominal scope of antidepressant benzodiazepines specifically, the code shows little decision-relevant activity for vendors targeting that product category in state and local procurement.